Article
PDGF receptors as targets in tumor treatment.
Advances in cancer research - 1 Jan 2007
Ostman Arne, Heldin Carl-Henrik
Abstract excerpt
Signaling through platelet-derived growth factor (PDGF) receptors contributes to multiple tumor-associated processes. The recent introduction of clinically useful PDGF inhibitors have the last years validated PDGF receptors in malignant and stromal cells as relevant cancer drug targets. Mutational activation of PDGF receptor signaling in malignant cells has been described in some rare tumor types such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
